Personal information

No personal information available

Activities

Employment (3)

University of Kansas Medical Center: Kansas City, KS, US

2020-01-01 to present | Research Assistant Professor (Population Health)
Employment
Source: Self-asserted source
Aaron Katz

University of North Carolina Lineberger Comprehensive Cancer Center: Chapel Hill, NC, US

2017-03-13 to 2019-12-31 | Senior Research Associate (Radiation Oncology)
Employment
Source: Self-asserted source
Aaron Katz

Amgen Inc: Thousand Oaks, CA, US

2013-05-20 to 2017-02-28 | Manager/Senior Manager (Center for Observational Research)
Employment
Source: Self-asserted source
Aaron Katz

Education and qualifications (2)

University of North Carolina at Chapel Hill, Eshelman School of Pharmacy: Chapel Hill, NC, US

2008-08-01 to 2013-05-01 | PhD (Division of Pharmaceutical Outcomes and Policy)
Education
Source: Self-asserted source
Aaron Katz

Midwestern University College of Pharmacy - Glendale: Glendale, AZ, US

2005-08-01 to 2008-06-08 | PharmD
Education
Source: Self-asserted source
Aaron Katz

Works (22)

Differences in Rural Versus Urban Patients With Prostate Cancer in Diagnosis and Treatment: An Analysis of a Population-Based Cohort

JCO Oncology Practice
2024-08 | Journal article
Contributors: Xinglei Shen; Katelyn Kane; Aaron J. Katz; Deborah Usinger; Ying Cao; Ronald C. Chen
Source: check_circle
Crossref

Long-Term Trends in Decisional Regret Among Men with Localized Prostate Cancer

JU Open Plus
2024-04 | Journal article
Contributors: Alexandria Alverdy Spellman; Vishnukamal Golla; Li Lin; Aaron Katz; Ronald C. Chen; Leah L. Zullig
Source: check_circle
Crossref

Telehealth use and perceptions among prostate cancer survivors

Cancer Medicine
2023-08 | Journal article
Contributors: Luke W. Chen; Deborah S. Usinger; Aaron J. Katz
Source: check_circle
Crossref

Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors

Journal of Cancer Survivorship
2023-04 | Journal article
Contributors: Aaron J. Katz; Ronald C. Chen; Deborah S. Usinger; Susanne M. Danus; Leah L. Zullig
Source: check_circle
Crossref

Evaluation of Telemedicine Use Among US Patients With Newly Diagnosed Cancer by Socioeconomic Status.

JAMA Oncology
2022-01-01 | Journal article
Source: Self-asserted source
Aaron Katz

Prenatal antidepressant use and the implication of hypertensive disorders during pregnancy.

American Journal of Obstetrics and Gynecology
2021-06-08 | Journal article
Source: Self-asserted source
Aaron Katz

Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.

JAMA Oncology
2021-06-01 | Journal article
Source: Self-asserted source
Aaron Katz

Receipt of Guideline-Recommended Surveillance in a Population-Based Cohort of Prostate Cancer Patients Undergoing Active Surveillance.

International Journal of Radiation Oncology, Biology, Physics
2021-01-14 | Journal article
Source: Self-asserted source
Aaron Katz

Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia.

Clinical Lymphoma, Myeloma & Leukemia
2020-06-13 | Journal article
Source: Self-asserted source
Aaron Katz

Comparing the Effects of How Often Men Have PSA Testing in the First Year after Prostate Cancer Treatment

2020-05-26 | Report
Contributors: Aaron Katz; Ramsankar Basak; Ronald Chen
Source: check_circle
Crossref

Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.

Leukemia
2020-02-24 | Journal article
Source: Self-asserted source
Aaron Katz

The Impact of the Affordable Care Act on Disparities in Private and Medicaid Insurance Coverage Among Patients Under 65 With Newly Diagnosed Cancer.

International Journal of Radiation Oncology, Biology, Physics
2019-05-29 | Journal article
Source: Self-asserted source
Aaron Katz

Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data.

Leukemia & Lymphoma
2019-01-11 | Journal article
Source: Self-asserted source
Aaron Katz

Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with ALL.

Leukemia & Lymphoma
2018-12-13 | Journal article
Source: Self-asserted source
Aaron Katz

Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data.

Advances in Therapy
2016-11-21 | Journal article
Source: Self-asserted source
Aaron Katz

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Blood Cancer Journal
2016-09-23 | Journal article
Source: Self-asserted source
Aaron Katz

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.

Haematologica
2016-09-01 | Journal article
Source: Self-asserted source
Aaron Katz

Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.

Cancer Causes & Control
2015-09-16 | Journal article
Source: Self-asserted source
Aaron Katz

Assessment of case definitions for identifying acute liver injury in large observational databases.

Drug Safety
2013-08-01 | Journal article
Source: Self-asserted source
Aaron Katz

National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009.

Journal of Anxiety Disorders
2013-01-07 | Journal article
Source: Self-asserted source
Aaron Katz

Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services.

Journal of Pharmacy Practice
2012-11-25 | Journal article
Source: Self-asserted source
Aaron Katz

Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.

Pharmacotherapy
2012-03-01 | Journal article
Source: Self-asserted source
Aaron Katz

Peer review (2 reviews for 1 publication/grant)

Review activity for JNCI cancer spectrum. (2)